|
Summary:
(b)(6) l "[canada]" reported a potential false positive h.Influenzae result on the filmarray® meningitis/encephalitis (me) panel after testing a patient cerebrospinal fluid sample.The customer reported that due to the me panel result, that patient was indirectly impacted, specifically through unnecessary antibiotic treatment, which might lead to serious injury if it were to recur.No patient harm was reported.Biofire has requested further information from the customer and is currently investigating this event.No remedial action, corrective action, preventive action, or field safety corrective action (fsca) has been deemed necessary at this time.
|